“C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo Post Surgery and Radiation Therapy in Patients With High-Risk Cutaneous Squamous Cell Carcinoma”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s173. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1996.